// App-Quantinova.ai

145 : Investigating the direct implications of the dapa HF trial and the indroducton of sodium-glucose like co-transporter 2 (SGLT2) inhibitors on middlesbrough’s heart failure population

Researchers

Presenter

  • Samuel Richardson

Principal Investigators

  • Joshua Colman

  • Andrew Turley

Medical Centers

  • South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 1 diabetes mellitus

  • Congestive heart failure

  • Diabetes

  • Heart failure with reduced ejection fraction

Biomarkers

  • Hemoglobin A1c

Drug/Treatment

  • Dapagliflozin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved